Nusano

United States - Valencia, California

• 02/10/2024
• Series C
• $115,000,000

No patient should be denied the cancer care they need simply because some options are in short supply or unavailable. Yet, all too often, this is what happens.

Nusano is a physics company that creates radioisotopes—tiny tracers used by doctors to diagnose and treat cancer and other diseases. Doctors use these tiny tracers like flashlights to light up areas inside the body. They can see how blood is flowing, how organs are functioning, even how cells are growing. Advanced medicines and treatment methods also use radioisotopes to target and eliminate cancer cells with precision.

Health care has used radioisotopes for decades. But, if supply does not keep up with demand, patients will lose out on the benefits of these lifesaving, proven tools.

Nusano’s patented technologies and methods are poised to transform radioisotope production and usher in an exciting new era in cancer care. Our state-of-the-art facility in West Valley City, Utah will produce radioisotopes quickly, efficiently, and affordably. This will make desperately needed resources available to hospitals and cancer clinics around the world and offer those with life-threatening diseases hope for a healthier tomorrow.

Related People

Chris LoweFounder

United States - San Jose, California

I have over 15 years of senior management experience as CFO, CBO and CEO of various private and public life sciences, medical technology, and technology companies. Additionally, I have served as a member of the Board of Directors of both public and private companies, and have chaired their respective Audit Committees and Compensation Committees. My successes include assisting early stage companies with corporate and financial strategy, including seed financing, venture fundraising and IPOs, as well as Wall Street communications, licensing transactions, M&A, restructurings and coaching at every level of the C-Suite.

My C-level accomplishments include:
-raised over $500M in private and public financings
-completed over $1.0B in M&A transactions
-negotiated over $300M in debt instruments
-overseen three SOX-404 implementations

Contact me at clowe@flgpartners.com

LinkedIn https://www.linkedin.com/in/chrislowe7/